Page 86 - 《中国药房》2024年17期

·药师与药学服务·

全流程药学服务在心血管内科 FM35 病组患者药品成本管控中
的效果分析
Δ

1
1 #
2
1＊
曹文静 ，张 鹏 ，肖 灿 ，刘 湘 （1.湘潭市中心医院临床药学科，湖南 湘潭 411100；2.湘潭市中心医院
院前急救科，湖南 湘潭 411100）
中图分类号 R95 文献标志码 A 文章编号 1001-0408（2024）17-2136-06
DOI 10.6039/j.issn.1001-0408.2024.17.14

摘 要 目的 运用全流程药学服务优化心血管内科 FM35 病组患者药物治疗方案，实现保障患者用药安全并管控住院药品费
用的目标。方法 以2023年7－8月在我院心血管内科治疗出院的213例FM35病组患者为对照组，筛选其全部医嘱并运用复杂网
络分析法及我院药物评价标准制定优化治疗药物库。以2023年9月我院心血管内科新收治入院的83例FM35病组患者为干预
组，建立并应用政策宣讲-治疗方案干预的模式，对该组患者进行全流程药学服务。对比两组患者的治疗费用、住院日及出院转归
情况。结果 通过临床药师全流程药学服务，与对照组比较，干预组患者住院总费用、药品费用、药占比、疾病诊断相关分组（DRG）
费用超标病例比例均显著下降（P＜0.05），住院日中位数缩短1 d；两组患者的出院转归好转率均≥99%。结论 临床药师通过全
流程药学服务可在保证医疗质量的基础上有效提升医疗服务效率，节约医疗成本，有效助力DRG的顺利施行。
关键词 全流程药学服务；疾病诊断相关分组；临床药师；药品成本管控；复杂网络分析法；驻科服务

Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35
disease group
CAO Wenjing ，ZHANG Peng ，XIAO Can ，LIU Xiang （1. Dept. of Clinical Pharmacy， Xiangtan Central
2
1
1
1
Hospital， Hunan Xiangtan 411100， China；2. Dept. of pre-hospital emergency， Xiangtan Central Hospital，
Hunan Xiangtan 411100， China）
ABSTRACT OBJECTIVE To optimize drug treatment plans for patients in cardiovascular FM35 disease group using full-process
pharmaceutical services， and achieve the goals of ensuring patient medication safety and controlling drug costs. METHODS Overall
213 patients in the cardiovascular FM35 disease group who were discharged from July to August 2023 were selected as control
group； all medical orders were screened and complex network analysis and drug evaluation standards of our hospital were used to
establish an optimized treatment drug library； 83 FM35 patients who newly admitted to the cardiovascular department in September
2023 were selected as intervention group； a model of policy promotion-treatment plan intervention was established and applied to
provide full process pharmaceutical services to patients. The treatment cost， length of stay and outcome were analyzed and
compared between 2 groups. RESULTS Through the full process pharmaceutical services provided by clinical pharmacists，
compared with the control group， the total hospitalization cost， drug cost， drug proportion， and case proportion of medical
insurance settlement amount in the intervention group significantly decreased （P＜0.05）. The median length of hospital stay in the
intervention group was shortened by 1 d， and the discharge improvement outcome rates of both groups of patients were ≥99%.
CONCLUSIONS Clinical pharmacists can effectively improve the efficiency of medical services and save the medical costs through
full-process pharmaceutical services， meanwhile ensuring medical quality and safety. This can effectively assist in the smooth
implementation of DRGs.
KEYWORDS full process pharmaceutical services； DRG； clinical pharmacist； drug cost control； complex network analysis
method； residency pharmaceutical service

疾病诊断相关分组（diagnosis related groups，DRG）
Δ 基金项目 湖南省卫生健康委科研计划项目（No.D202313049086）；
湘潭市医学科研项目（No.2022-xtyx-22） 是根据患者年龄、疾病诊断、合并症、并发症、治疗方式、
＊第一作者 主管药师，硕士。研究方向：临床药学。E-mail： 病症严重程度及转归等因素，将临床治疗过程和费用消
241927432@qq.com
耗相似的病例作为一个诊断相关组，国家医保依照病例
# 通信作者 主任药师。研究方向：药事管理。E-mail：LX19890@
[1]
163.com 所进入的分组按固定预付费标准进行结算 。为此，加

· 2136 · China Pharmacy 2024 Vol. 35 No. 17 中国药房 2024年第35卷第17期